Benzenedicarboxylic acid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S379100, C548S379400, C548S379700, C549S491000, C549S492000, C549S496000, C514S461000, C514S471000

Reexamination Certificate

active

06852750

ABSTRACT:
New benzenedicarboxylic acid derivative compounds; pharmaceutical compositions, diagnostic methods, and diagnostic kits that include those compounds; and methods of using those compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis, and treating glutamate abnormalities, neuropathy, pain, compulsive disorders, prostate diseases, cancers, and glaucoma.

REFERENCES:
patent: 4250182 (1981-02-01), Gorvin
patent: 4863636 (1989-09-01), Chang et al.
patent: 5498784 (1996-03-01), Arnold et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5807688 (1998-09-01), Blackburn et al.
patent: 5824662 (1998-10-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5880309 (1999-03-01), Suzuki et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5977090 (1999-11-01), Slusher et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 5985855 (1999-11-01), Slusher et al.
patent: 6004946 (1999-12-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6028216 (2000-02-01), Morales et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6071965 (2000-06-01), Jackson et al.
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6228888 (2001-05-01), Slusher
patent: 651-91 (1998-02-01), None
patent: 0745673 (1996-12-01), None
patent: 2-204754 (1990-08-01), None
patent: 2-208666 (1990-08-01), None
patent: 11-269182 (1999-10-01), None
patent: 2000-95788 (2000-04-01), None
patent: 2000-159984 (2000-06-01), None
patent: 6606892 (1967-07-01), None
C.A. 66:3730 (Abstract of NL 6606892).
C.A. 79:147536 (Abstract of M. Erickson et al., Acta Chem. Scand. (1973), 27(5), 1673-8).
C.A. 85:177080 (Abstract of V. Kudlacek et al., CS 162594).
C.A. 94:214626 (Abstract of US 4250182).
C.A. 105:190584 (Abstract of A. El-Maghraby et al., Egypt. J. Pharm. Sci. (1985), vol. Date 1983, 24(1-4), 105-15).
C.A. 124:219572 (Abstract of P. Wentworth et al., Proc. Natl. Acad. Sci. USA (1996), 93(2), 799-803).
C.A. 126:70131 (Abstract of EP 0745673).
C.A. 129:81601 (Abstract of M. Pickert et al., Arch. Pharm. (1998), 331(5), 177-192).
Watson, S., et al., “TiPS Receptor and Ion Channel Nomenclature Supplement 1995,” pp. 1 and 30-32,Elsevier Trends Journals, 6thEd., United Kingdom (ISBN 1357-485X).
WPINDEX Abstract for JP-2-204754.
WPINDEX Abstract for JP-2-208666.
WPINDEX Abstract for JP-11-269182.
WPINDEX Abstract for JP-2000-95788.
WPINDEX Abstract for JP-2000-159984.
Watson, S., et al., “TiPS Receptor and Ion Channel Nomenclature Supplement 1995,” pp. 1 and 30-32,Elsevier Trends Journals, 6thEd., United Kingdom (ISBN 1357-485X).
Wentworth, et al., “Antibody Catalysis of BAC2 Aryl Carbamate Ester Hydrolysis: A Highly Disfavored Chemical Process,”Journal of the American Chemical Society, 1997, vol. 119, No. 9, pp. 2315-2316.
Wentworth, et al., “Toward antibody-directed ‘abzyme’ prodrug therapy, ADAPT: Carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing,”Proceedings of the National Academy of Sciences of the United States of America, 1996, vol. 93, No. 2, pp. 799-803.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzenedicarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzenedicarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzenedicarboxylic acid derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3450841

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.